Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Shuttle Pharmaceuticals Holdings Inc (SHPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,826
  • Shares Outstanding, K 3,665
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,590 K
  • EBIT $ -7 M
  • EBITDA $ -5 M
  • 60-Month Beta -1.70
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.15
  • Most Recent Earnings $-1.59 on 11/13/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5800 +37.33%
on 12/19/24
0.8610 -7.49%
on 12/03/24
-0.0735 (-8.45%)
since 11/26/24
3-Month
0.5800 +37.33%
on 12/19/24
2.2500 -64.60%
on 10/29/24
-0.5535 (-41.00%)
since 09/26/24
52-Week
0.5800 +37.33%
on 12/19/24
4.9464 -83.90%
on 01/19/24
-2.8491 (-78.15%)
since 12/26/23

Most Recent Stories

More News
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

SHPH : 0.7965 (+3.31%)
Shuttle Pharmaceuticals Announces First Patient Enrollment in Phase 2 Clinical Trial of Ropidoxuridine for Glioblastoma Treatment at UVA Cancer Center

Shuttle Pharma enrolls first patient in Phase 2 trial for Ropidoxuridine, targeting glioblastoma treatment at UVA Cancer Center.Quiver AI SummaryShuttle Pharmaceuticals Holdings, Inc. has announced the...

SHPH : 0.7965 (+3.31%)
Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

SHPH : 0.7965 (+3.31%)
Shuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma Treatment

Shuttle Pharmaceuticals reports progress in its Phase 2 trial of Ropidoxuridine for glioblastoma and financial updates.Quiver AI SummaryShuttle Pharmaceuticals Holdings, Inc. has announced significant...

SHPH : 0.7965 (+3.31%)
Shuttle Pharma Provides Third Quarter 2024 Corporate Update

SHPH : 0.7965 (+3.31%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.7965 (+3.31%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.7965 (+3.31%)
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

SHPH : 0.7965 (+3.31%)
Shuttle Pharma Pays Off Senior Secured Convertible Note

SHPH : 0.7965 (+3.31%)
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

SHPH : 0.7965 (+3.31%)

Business Summary

Shuttle Pharmaceuticals Holdings Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy. Shuttle Pharmaceuticals Holdings Inc. is based in ROCKVILLE, Md.

See More

Key Turning Points

3rd Resistance Point 0.9043
2nd Resistance Point 0.8522
1st Resistance Point 0.8243
Last Price 0.7965
1st Support Level 0.7443
2nd Support Level 0.6922
3rd Support Level 0.6643

See More

52-Week High 4.9464
Fibonacci 61.8% 3.2784
Fibonacci 50% 2.7632
Fibonacci 38.2% 2.2480
Last Price 0.7965
52-Week Low 0.5800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar